The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

Share Price Information for Induction Heal. (INHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 11.00
Ask: 14.00
Change: 0.00 (0.00%)
Spread: 3.00 (27.273%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
INHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

7 Jun 2022 07:00

RNS Number : 9023N
Induction Healthcare Group PLC
07 June 2022
 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Directorate Change

Appointment of new Chairman

 

Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces that Christopher Samler has been appointed as Non-Executive Chairman. Christopher takes over from Chris Spencer, with immediate effect, after an externally facilitated recruitment process.

 

Christopher has held a number of roles as Chief Executive Officer and Chair of quoted companies (both Main Market and AIM) and private businesses in the education, healthcare, services and technology sectors. He also has significant experience supporting growth for businesses across the U.S. and Europe, as well as emerging economies in Asia, Latin America and the Middle East.

 

Christopher started his career in the British Army before joining The Boston Consulting Group as an analyst which led to a variety of senior general management positions at Baxter International, the US-based healthcare multinational. Subsequently, Christopher was Chief Executive Officer of a series of fast-growing venture capital backed healthcare businesses including Imutran Ltd and Weston Medical plc, the latter of which he took through three venture capital funding rounds to an IPO on the Main Market of the London Stock Exchange in 2000.

 

In 2004, Christopher co-founded Iceni Capital LLP, a successful private equity / venture capital firm focused on providing capital and operational support to fast growing UK companies in the services sector. More recently, he has chaired a number of high growth technology, healthcare and service companies including TQ Education & Training, AirPortr, Sphonic Solutions, Bubble and Tristel plc.

 

Christopher holds an MA (hons) from the University of Oxford and an MBA from the Harvard Business School.

 

Chris Spencer is leaving, following the completion of his three year term, to pursue non-commercial projects and spend more time with his family.

 

Chris Spencer, former Chair said: "Having chaired the Board since the Company's IPO, I am pleased to be departing at a time when Induction has strongly ended the financial year to 31 March 2022, announced substantial contract renewals, and successfully begun a period of transition into a growth phase."

 

Induction CEO, James Balmain, said: "I am thrilled to welcome Christopher to the Board of Induction and look forward to working alongside him. Christopher has a wealth of directly relevant expertise that will be invaluable as we drive the business through this next phase of growth.

 

"I would like to genuinely thank Chris Spencer for the great contribution he's made to Induction and the support he's given me personally as a first time public markets CEO. Chris leaves Induction in a strong position, with solid foundations and a very bright future. I wish him the very best for the future."

 

Disclosures in accordance with the AIM Rules

 

Mr. Christopher Hadley Samler, 64, is, or has been, a director or partner of the following companies or partnerships during the past five years:

 

Current directorships and partnerships:

Cwm Cloch MJC Hydro Ltd

Airportr Technologies Limited

Tribo Technologies Limited

Nant Hir Hydro Scheme Limited

Maes Elwy Hydro Limited

 

Previous directorships and partnerships held in the past five years:

Creeton with Counthorpe Broadband Community Interest Company (dissolved)

Symphonic Solutions Limited

Future Digital Footprint Limited

La Salle Education Limited

Laundrapp Limited

 

Mr. Samler owns no shares in Induction.

 

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

-ENDS-

 

ENQUIRIES

 

Induction

James Balmain, Chief Executive Officer

Via Walbrook PR Ltd: induction@walbrookpr.com

Guy Mitchell, Chief Financial Officer

 

 

Singer Capital Markets (Nominated Adviser and Broker)

+44 (0) 20 7496 3000

Philip Davies / Kailey Aliyar

 

 

Walbrook PR Ltd 

+44 (0)20 7933 8780 or induction@walbrookpr.com

Alice Woodings / Paul McManus

Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

 

 

About Induction -  www.inductionhealthcare.com

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles. 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPURCQUPPGQQ
Date   Source Headline
15th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSInduction Attend Anywhere wins DWP contract
4th Nov 202110:52 amRNSResult of AGM
4th Nov 20217:00 amRNSAGM Statement
25th Oct 20217:00 amRNSReport on Video Consultations in Secondary Care
28th Sep 20217:00 amRNSPublication of Annual Report & Notice of AGM
23rd Sep 20217:00 amRNSFinal results for the year ended 31 March 2021
7th Sep 20217:00 amRNSDirectorate Changes
2nd Sep 20219:16 amRNSHolding(s) in Company
31st Aug 202111:04 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSBlock Listing Application
20th Jul 20217:00 amRNSMajor contract renewed with increased scope
16th Jun 20213:45 pmRNSHolding(s) in Company
11th Jun 20218:00 amRNSHolding(s) in Company
10th Jun 20214:18 pmRNSHolding(s) in Company
9th Jun 20218:00 amRNSCompletion of Acquisition of Attend Anywhere
8th Jun 20215:18 pmRNSHolding(s) in Company
7th Jun 202110:20 amRNSResult of General Meeting
21st May 20217:00 amRNSProposed Acquisition of Attend Anywhere Pty Ltd
18th May 20212:06 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:06 amRNSSecond Price Monitoring Extn
18th May 202111:01 amRNSPrice Monitoring Extension
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSMultiple new hospital contracts for InductionZesty
25th Mar 20217:00 amRNSMulti-year hospital contract for Induction Switch
22nd Mar 20217:00 amRNSZesty surpasses 200k registered patients in the UK
15th Mar 20217:00 amRNSNHS contract wins for Induction Booking
10th Mar 20217:00 amRNS1m UK hospital appointments booked since Oct 2020
8th Mar 20217:00 amRNSNew public sector contracts for Induction Booking
4th Mar 20217:00 amRNSChange of Adviser
19th Jan 20218:00 amRNSDirectorate Change
13th Jan 20217:00 amRNSRFL selects Induction to deliver patient portal
10th Dec 20207:00 amRNSHalf year results
27th Oct 20207:00 amRNSInduction aids rollout of Health Records on iPhone
12th Oct 20207:00 amRNSStrategic Collaboration Between Cerner & Induction
21st Sep 202010:24 amRNSResult of AGM
1st Sep 20207:00 amRNSInduction: Horizon achieves earn-out target
28th Aug 20207:00 amRNSNamed Supplier on NHSX Procurement Framework
6th Aug 202010:00 amRNSAnnual Report and Accounts and Notice of AGM
6th Aug 20207:00 amRNSFull year results for the year ended 31 March 2020
29th Jul 20207:00 amRNSNotice of Results
16th Jul 20201:05 pmRNSHoldings in Company
9th Jun 20205:58 pmRNSHolding(s) in Company
9th Jun 20208:34 amRNSDirector/PDMR Shareholding
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.